Trouble in Trialville: Plans for Post-DES Clopidogrel Trial Get Bogged Down Over Trial Design, Leadership. 04/13/2008- Almost 16 months after an FDA hearing into drug-eluting stent (DES) safety emphasized the need for a randomized clinical trial to determine, once and for all, the optimal duration of clopidogrel (Plavix, Sanofi-Aventis) plus aspirin after DES implantation, researchers, government agencies, and industry sponsors cannot agree on how it should move ahead.More>>>
Increased Rate of Heart Attack, Death Linked to Halting Plavix -Wall Street Journal
02/06/2008 - Patients treated for heart attack or angina and given the anticlotting drug Plavix had a sharply increased rate of death or heart attack within 90 days after being taken off the drug, researchers found. More>>
Whistleblowers Responsible for Half-Billion Dollar Fraud Recovery Against Bristol Myers -National Whistleblower Center
10/1/2007- Several whistleblowers provided confidential information to the United States Department of Justice which resulted in a $515 million taxpayer recovery against the drug company Bristol Myers to settle health care fraud allegations. More>>